• Dapagliflozin Gets Expanded Heart Failure Indication in Europe

    1 month ago - By Medscape

    The European Commission has expanded the indication of the SGLT2 inhibitor to include HF with mildly reduced and preserved ejection fraction, based on the DELIVER phase 3 trial.
    International Approvals
    Read more ...